The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Nanotechnology and aptamers: applications in drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
Cerchia, L., Ducongé, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., & Libri, D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030123 · Cited by 246
RetractedTuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Self-citationSelection of single-stranded DNA molecules that bind and inhibit human thrombin
Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H., & Toole, J. J. (1992) · Nature · doi:10.1038/355564a0 · Cited by 2,469
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationAptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,430
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Self-citationInterfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Self-citationCell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Self-citationRuckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Label-Free Protein Biosensor Based on Aptamer-Modified Carbon Nanotube Field-Effect Transistors
Maehashi, K., Katsura, T., Kerman, K., Takamura, Y., Matsumoto, K., & Tamiya, E. (2007) · Analytical Chemistry · doi:10.1021/ac060830g · Cited by 660
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Self-citationDaniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., & Gold, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136683100 · Cited by 567
Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
Huang, C.-C., Huang, Y.-F., Cao, Z., Tan, W., & Chang, H.-T. (2005) · Analytical Chemistry · doi:10.1021/ac050957q · Cited by 542
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Aptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells
Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D., & Tan, W. (2006) · Analytical Chemistry · doi:10.1021/ac052015r · Cited by 431
Ferreira, C. S. M., Matthews, C. S., & Missailidis, S. (2006) · Tumor Biology · doi:10.1159/000096085 · Cited by 407
Inhibitory DNA Ligands to Platelet-Derived Growth Factor B-Chain
Green, L. S., Jellinek, D., Jenison, R., Östman, A., Heldin, C.-H., & Janjic, N. (1996) · Biochemistry · doi:10.1021/bi961544+ · Cited by 390
Tumor targeting by an aptamer.
Hicke, B. J., Stephens, A. W., Gould, T. A., Chang, Y.-F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S., et al. (2006) · PubMed · Cited by 384
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
Liu, J., Mazumdar, D., & Lu, Y. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200603106 · Cited by 346
Light-switching excimer probes for rapid protein monitoring in complex biological fluids
Yang, C. J., Jockusch, S., Vicens, M., Turro, N. J., & Tan, W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508821102 · Cited by 337
A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA
Wang, K. Y., McCurdy, S., Shea, R. G., Swaminathan, S., & Bolton, P. H. (1993) · Biochemistry · doi:10.1021/bi00059a003 · Cited by 332
Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels
Blank, M., Weinschenk, T., Priemer, M., & Schluesener, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100347200 · Cited by 326
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Kim, E. S., Serur, A., Huang, J., Manley, C. A., McCrudden, K. W., Frischer, J. S., Soffer, S. Z., Ring, L., New, T., Zabski, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398399 · Cited by 312
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationCell‐Specific Internalization Study of an Aptamer from Whole Cell Selection
Xiao, Z., Shangguan, D., Cao, Z., Fang, X., & Tan, W. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701330 · Cited by 246
Lee, J.-H., Canny, M. D., De Erkenez, A., Krilleke, D., Ng, Y.-S., Shima, D. T., Pardi, A., & Jucker, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509069102 · Cited by 242
Girvan, A. C., Teng, Y., Casson, L. K., Thomas, S. D., Jüliger, S., Ball, M. W., Klein, J. B., Pierce, W. M., Barve, S. S., & Bates, P. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0361 · Cited by 235
Gene therapy progress and prospects: RNA aptamers
Que-Gewirth, N. S., & Sullenger, B. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302900 · Cited by 227
Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
Pagratis, N. C., Bell, C., Chang, Y.-F., Jennings, S., Fitzwater, T., Jellinek, D., & Dang, C. (1997) · Nature Biotechnology · doi:10.1038/nbt0197-68 · Cited by 221
Pashenkov, M., Goëss, G., Wagner, C., Hörmann, M., Jandl, T., Moser, A., Britten, C. M., Smolle, J., Koller, S., Mauch, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9129 · Cited by 210
Chen, C.-H. B., Chernis, G. A., Hoang, V. Q., & Landgraf, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332660100 · Cited by 190
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Fitzwater, T., & Polisky, B. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)67019-0 · Cited by 172
Crystal structure of NF-κB (p50) 2 complexed to a high-affinity RNA aptamer
Huang, D.-B., Vu, D., Cassiday, L. A., Zimmerman, J. M., Maher, L. J., & Ghosh, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632011100 · Cited by 167
Labeling tumor cells with fluorescent nanocrystal–aptamer bioconjugates
Chu, T. C., Shieh, F., Lavery, L. A., Levy, M., Richards-Kortum, R., Korgel, B. A., & Ellington, A. D. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2005.12.015 · Cited by 160
Cox, J. C., Rudolph, P., & Ellington, A. D. (1998) · Biotechnology Progress · doi:10.1021/bp980097h · Cited by 156
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
Jellinek, D., Lynott, C. K., Rifkin, D. B., & Janjić, N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11227 · Cited by 149
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146
Eulberg, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni044 · Cited by 140
Ducongè, F., & Toulmé, J. (1999) · RNA · doi:10.1017/s1355838299991318 · Cited by 132
RNAs that bind and change the permeability of phospholipid membranes
Khvorova, A., Kwak, Y., Tamkun, M. M., Majerfeld, I. H., & Yarus, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10649 · Cited by 128
Boiziau, C., Dausse, E., Yurchenko, L., & Toulmé, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12730 · Cited by 121
Toward third-generation aptamers: Spiegelmers and their therapeutic prospects.
Vater, A., & Klußmann, S. (2003) · PubMed · Cited by 91
Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product
Bardeesy, N. M., & Pelletier, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.7.1784 · Cited by 85
Mi, J., Zhang, X., Giangrande, P. H., McNamara, J. O., Nimjee, S. M., Sarraf‐Yazdi, S., Sullenger, B. A., & Clary, B. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.043 · Cited by 74
Anti‐(Raf‐1) RNA aptamers that inhibit Ras‐induced Raf‐1 activation
Kimoto, M., Shirouzu, M., Mizutani, S., Koide, H., Kaziro, Y., Hirao, I., & Yokoyama, S. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02703.x · Cited by 49
Bellecave, P., Andréola, M., Ventura, M., et al. (2003) · Oligonucleotides · doi:10.1089/154545703322860771 · Cited by 45
Bennett, C. F., Chiang, M.-Y., Wilson-Lingardo, L., & Wyatt, J. R. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3202 · Cited by 28
RNA aptamers that specifically bind to the Ras‐binding domain of Raf‐1
Kimoto, M., Sakamoto, K., Shirouzu, M., Hirao, I., & Yokoyama, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01572-5 · Cited by 21
Cited by
Activatable Photosensitizers for Imaging and Therapy
Lovell, J. F., Liu, T. W. B., Chen, J., & Zheng, G. (2010) · Chemical Reviews · doi:10.1021/cr900236h · Cited by 1,717
Drug delivery by supramolecular design
Webber, M. J., & Langer, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00391a · Cited by 814
Self-citationMishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Aptamer-integrated DNA nanostructures for biosensing, bioimaging and cancer therapy
Meng, H.-M., Liu, H., Kuai, H., Peng, R., Mo, L., & Zhang, X.-B. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00645g · Cited by 608
Smart Drug Delivery Nanocarriers with Self‐Assembled DNA Nanostructures
Li, J., Fan, C., Pei, H., Shi, J., & Huang, Q. (2013) · Advanced Materials · doi:10.1002/adma.201300875 · Cited by 441
Metadata
- Authors
- Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 26
- Issue
- 8
- Pages
- 442-449
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2106249361
- Cited by
- 270
- References
- 60
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.